The spatial distribution of cell-cycle-related genes allowed us to distinguish 2 distinctive tumor phenotypes (high-CL4 and low-CL5 proliferation) with potential clinical implications especially when using replicative stress or DNA-damaging agents, as differences in replication can correlate with different responses to treatment13,14. The gene discussed is KIR3DL2; the disease is neoplasm.